A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer.
Cancer 2013 May 119 (10): 1823-31.
Fury Matthew G, Sherman Eric, Ho Alan L, Xiao Han, Tsai Frank, Nwankwo Oby, Sima Camelia, Heguy Adrian, Katabi Nora, Haque Sofia, Pfister David
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 22, 2019
- Content source: